Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours

16 Mar 2022

Abstract excerpt

AIM: Rosette-forming glioneuronal tumour (RGNT) is a rare central nervous system (CNS) World Health Organization (WHO) grade 1 brain neoplasm. According to the WHO 2021, essential diagnostic criteria are a 'biphasic histomorphology with neurocytic and a glial component, and uniform neurocytes forming rosettes and/or perivascular pseudorosettes associated with synaptophysin expression' and/or DNA methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Meningioma and schwannoma management
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35293634
DOI: 10.1111/nan.12813

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumoursPMID 35293634Read ↗

Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.Semantic proximity Read ↗

Clinicopathological analysis of rosette-forming glioneuronal tumors.Semantic proximity Read ↗

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.Semantic proximity Read ↗

Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.Semantic proximity Read ↗

Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series.Semantic proximity Read ↗

Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal CordSemantic proximity Read ↗

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.Semantic proximity Read ↗

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsSemantic proximity Read ↗

Rosette‑forming glioneuronal tumor in the Posterior Fossa: Case Report and Literature ReviewSemantic proximity Read ↗

Multifocal Rosette-forming Glioneuronal Tumor-like Low-Grade Glioneuronal Tumor with Dysembryoplastic Neuroepithelial Tumor Features Associated with Drug-Resistant Epilepsy: A Case Report and Literature ReviewSemantic proximity Read ↗

FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.Semantic proximity Read ↗

Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.